<DOC>
	<DOCNO>NCT03067415</DOCNO>
	<brief_summary>Exploratory trial evaluate efficacy safety D565H twice daily versus D565 daily .</brief_summary>
	<brief_title>Exploratory Trial Evaluate Efficacy Safety D565H Twice Daily Versus D565 Once Daily</brief_title>
	<detailed_description>A Multi center , Randomized , Double-blind , Parallel design , Exploratory trial evaluate efficacy safety D565H twice daily versus D565 daily primary open angle glaucoma ocular hypertension patient .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>1 . More age 19 year old 2 . Subjects primary OpenAngle Glaucoma Ocular Hypertension 3 . Subjects sign inform consent form willingly 1 . Subjects IOP ( Intraocular Pressure ) measure Visit 1 Visit 2 ( AM 09:00 ) 35 mmHg one eye 2 . Subjects maximum correct visual acuity le 0.3 select evaluation eye visit 2 3 . Subjects diagnose monocular eye Acute Chronic ClosedAngle Glaucoma Secondary Glaucoma Pseudoexfoliation Glaucoma Neovascular Glaucoma aphakia phacocyst capsular torn intraocular lens 4 . Subjects significant eye symptoms/signs ( Abscesses , diplopia ) severe visual field impairment ( Mean Deviation 25dB ) 5 . Subjects severe dry eye syndrome progressive retinal disease ( Retinal degeneration , Diabetic retinopathy , Retinal detachment , Macular edema ) 6 . Subjects inflammatory/infectious eye disease active eye disease within last 3 month 7 . Subjects medical history follow Glaucoma surgery Subjects significant history ocular trauma last 6 month , underwent surgical ophthalmic surgery Subjects receive topical systemic steroid within last 6 month 8 . Subjects wear need wear contact lenses study 9 . Subjects drug interaction investigational product , significant effect intraocular pressure , may effect clinical trial result 10 . Subjects know hypersensitivity investigational product 11 . Women nurse , pregnant planning pregnancy study 12 . Subjects bronchial asthma history 13 . Subjects receive investigational product within 1 month prior first dose 14 . Impossible subject participate clinical trial investigator 's decision</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Glaucoma , Primary Open Angle</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>CKD-351</keyword>
</DOC>